Drug Database
SO

sodium ferrous citrate (SCF, Eisai / Ferromia / Nemiffero)

✓ Approved

Eisai Co., Ltd. · Small Molecule · Small Molecule

What is sodium ferrous citrate?

sodium ferrous citrate is a small molecule developed by Eisai Co., Ltd.. It is approved for therapeutic indications.

Drug Profile

Brand NamesSCF, Eisai, Ferromia, Nemiffero
CompanyEisai Co., Ltd.
Drug ClassSmall Molecule
StatusApproved

Therapeutic Indications

sodium ferrous citrate is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Blood and lymphatic system disordersAnaemia✓ Approved

Related Research Articles

PubMedEvidence-based dentistry2026-10-15

How do different topical fluoride applications affect salivary and plaque fluoride levels for young children with dental caries?

Timms Laura L, Marshman Zoe Z

Asavalertpalakorn C, Jirarattanasopha V, Nakornchai S, Horsophonphong S. Plaque and salivary fluoride levels in preschoolers following applications of silver diamine fluoride, sodium fluoride varnish, and their combination: a randomized clinical trial. Int J Paediatr Dent. 2026;36:81-9. https://doi.org/10.1111/ipd.70030 . A three-arm randomised controlled trial compared the salivary and plaque fluoride levels for young children, following application of different fluoride prevention and treatment procedures (silver diamine fluoride, sodium fluoride varnish and silver diamine fluoride and sodium fluoride varnish together), in child development centres in Thailand. Children aged 3-6 were selected who had at least one carious tooth reaching dentine in the primary dentition. Included children were considered healthy and co-operative. Children who had received professional fluoride application within the last three months were excluded, or those with a known allergy to any component. Twenty children were randomised to each group. Group 1 received silver diamine fluoride application (1 drop) to dentinal carious lesions; group 2 received sodium fluoride varnish application (0.25 ml) to all erupted primary teeth; group 3 received both the silver diamine fluoride and sodium fluoride varnish interventions. Fluoride applications were not applied to pulpally involved teeth. Plaque and saliva samples were collected at baseline (prior to fluoride application), at 5, 30 and 60 minutes, and at 24 and 48 hours. Kruskal-Wallis and Friedman tests were used to compare the 3 groups at the various time points. A Bonferroni correction was applied to account for the multiple comparisons. In total, 60 children were randomised, data were analysed for 50 children's salivary samples and 49 children's plaque samples. The mean age was 3.7 months, with children having a mean of 7.6 decayed, missing or filled teeth. At the shorter-term (5, 30 and 60 minute) time points, the salivary fluoride levels were significantly higher in the sodium fluoride varnish alone and silver diamine fluoride with sodium fluoride varnish groups than in the silver diamine fluoride alone group. There was no difference in the silver diamine fluoride with sodium fluoride varnish and sodium fluoride varnish alone groups for both salivary and plaque fluoride levels. Considering fluoride levels in plaque, the sodium fluoride varnish group had significantly higher levels at 5 and 60 minutes than the silver diamine fluoride group and the silver diamine fluoride with sodium fluoride varnish group was significantly higher at 30 and 60 minutes in comparison to silver diamine fluoride alone. At 60 minutes, the silver diamine fluoride and sodium fluoride varnish groups had returned to baseline; this was at 24 hours for the silver diamine fluoride with sodium fluoride varnish group for salivary fluoride. For plaque levels, the return to baseline was at 60 minutes for the silver diamine fluoride group, and 24 hours for the sodium fluoride varnish and silver diamine fluoride with sodium fluoride varnish groups. Children receiving sodium fluoride varnish and silver diamine fluoride had higher plaque and salivary fluoride levels than those treated with silver diamine fluoride alone in the short term. Plaque and salivary fluoride levels returned to baseline at 24 hours for all groups.

PubMedFrontiers in medicine2026-10-15

Risk factors for recurrent variceal bleeding after TIPS in cirrhotic patients with esophagogastric variceal hemorrhage: a single-center retrospective study.

Chen Zhiliang Z, Gou Yi Y, Li Wenke W, Yu Daowu D et al.

Transjugular intrahepatic portosystemic shunt (TIPS) effectively reduces portal pressure but post-procedural rebleeding remains a major clinical challenge. Risk factors for rebleeding are not fully defined. This single-center retrospective cohort study included 114 cirrhotic patients who underwent TIPS for EGVB (2019-2024). Patients were categorized into rebleeding (n = 35) and non-rebleeding (n = 79) groups based on 1-year post-TIPS rebleeding. Clinical, laboratory, procedural, prior endoscopic treatment history and follow-up data were analyzed. Univariate and multivariate Cox proportional hazards models were used to identify risk factors. Cumulative rebleeding incidence was compared between serum sodium groups (<135 vs. ≥135 mmol/L) using Kaplan-Meier analysis with log-rank test. The 1-year rebleeding rate was 30.7% (35/114). Multivariate Cox regression identified lower serum sodium (HR = 0.85; 95% CI: 0.77-0.93; P < 0.001) and shunt dysfunction (HR = 4.60; 95% CI: 2.21-9.58; P < 0.001) as independent risk factors for rebleeding. Stent type was not independently associated after adjustment. The low sodium group (<135 mmol/L) showed a significantly higher cumulative rebleeding incidence than the high sodium group (log-rank P = 0.041). Conclusion: Serum sodium preoperatively and post-TIPS shunt dysfunction are independent risk factors for 1-year rebleeding. Optimizing serum sodium preoperatively and implementing regular surveillance for shunt dysfunction may help reduce rebleeding risk in these patients.

PubMedAngewandte Chemie (International ed. in English)2026-10-15

Rotation-Coupled Guest Anions Stabilize Polymer Solid-State Sodium-Metal Batteries.

Li Yi Y, Wang Lifeng L, Ling Fangxin F, Wang Ziyang Z et al.

Polymer solid-state sodium-metal batteries are constrained by sluggish Na+ migration and unstable sodium-metal interfaces, both of which are closely associated with poorly regulated solvation chemistry. Here we report a rotation-coupled guest-anion strategy in a poly(vinylidene fluoride-co-hexafluoropropylene)-based solid-state electrolyte (PHSE) using Mg(OTf)2. Mg2+ preferentially coordinates DMF and TFSI-, weakening Na+-TFSI- association and limiting solvent-derived reactions at the sodium metal anode. OTf- enters the Na+ solvation shell as a mobile guest anion. Its C─S rotational axis and equivalent oxygen coordination sites allow conformational rotation to synchronize with Na+ hopping along polymer chains. This anchor-rotator chemistry reorganizes Na+ coordination, lowers the migration barrier, and promotes an inorganic-rich, Mg─O-containing interphase. The optimized electrolyte enables Na3V2(PO4)3||Na cells to retain 94.2% capacity after 1100 cycles at 2C and supports a 94 mAh pouch cell with stable cycling. It also enables high-voltage Na3V2(PO4)2O2F||Na cells to retain 93.6% capacity after 1000 cycles at 0.5C over 2.5-4.2 V. Comparative evaluation across a total of 20 polymer electrolyte systems with varied polymer matrices and anion structures identifies anion symmetry, rotational periodicity, and finite rotational barriers as molecular criteria for designing stable polymer solid-state sodium-metal batteries.

PubMedJournal of clinical apheresis2026-10-15

Apheresis in Children of Weight Under 7 kg-A Single Center Experience.

Rungsiprakarn Phassawan P, Wilson Bryan E BE, Rintoul Natalie E NE, Wild K Taylor KT et al.

Although apheresis techniques in children are well established, published experience with very low-weight children is limited. We reviewed 68 procedures performed in 19 children weighing less than 7 kg, including hematopoietic progenitor and T-cell collections and plasmapheresis. With significant modifications of standard techniques, all but one procedure was successfully and safely completed without serious citrate toxicity. Access was a major challenge. For plasmapheresis, the mean plasma volume removed was 1.2 × total plasma volume, but the mean total blood processed was 1.74 × total blood volume (TBV). For collections, the mean number of whole blood volumes processed was 4.1 × TBV. For T cell collections, the median CD3+ yield was 243.6 × 106/kg. For HPC collections, the median CD34+ cell yield was 14.8 × 106/kg. Mean durations for collections and plasmapheresis were 247.00 and 120.67 min, respectively. Of the CBC parameters, only platelet count was significantly lower after collections.

PubMedFrontiers in veterinary science2026-10-15

Comparative analysis of feeding probiotic and exogenous buffer on growth performance, nutrient utilization, blood biochemistry, rumen fermentation pattern and carcass characteristics of crossbred lambs reared under feedlot.

Sahib Qazi Shehriyar QS, Ahmed Haidar Ali HA, Aafaq Ifla I, Farooq Javid J et al.

Feedlot nutrition is formulated to maximize growth rate and feed efficiency for high-quality meat production; however, high-grain diets can disrupt rumen function and cause digestive disorders, the inclusion of non-nutritive feed additives helps counter these effects, thereby enhancing growth performance and overall feed efficiency. The present study was carried out to delineate the effect of feeding Saccharomyces cerevisiae strain 1,026 as probiotic and sodium bicarbonate as exogenous buffer on performance of feedlot crossbred lambs. Fifteen crossbred lambs were selected and divided equally into three treatment groups viz., FT, FT-P and FT-SB. In FT group, animals were fed feedlot diet only; while in FT-P and FT-SB groups, Saccharomyces cerevisiae and sodium bicarbonate were offered as feed additives, respectively. A 74-days feeding trial was conducted, including 10-days metabolism trial at the end. No effect (p > 0.05) was observed in dry matter intake (DMI), body weight indices, feed conversion ratio (FCR), digestibility coefficients of nutrients and haemato-biochemical parameters. Rumen pH was significantly (p < 0.05) higher in FT-P group than FT group. Dressing percentage showed significantly (p < 0.05) higher values in FT-P group. The present experiment validates that feeding of Saccharomyces cerevisiae had more beneficial effect than sodium bicarbonate feeding on the performance of feedlot lambs.

PubMedPharmacological reports : PR2026-10-15

GLS2 reshapes glycolytic metabolism and bioenergetic homeostasis in glioblastoma cells.

De Los Santos-Jiménez Juan J, Campos-Sandoval José A JA, Sudderth Jessica J, Zacharias Lauren G LG et al.

Glioblastoma (GBM) exhibits extensive metabolic reprogramming, including glucose and glutamine (Gln) addiction, with Gln being converted into glutamate by glutaminase, encoded by the GLS and GLS2 genes. GLS2 acts as a context-dependent tumor suppressor, although the underlying mechanisms remain poorly understood. GLS2 is silenced in GBM, and we previously showed that its re-expression modulates pyruvate dehydrogenase (PDH) activity and tricarboxylic acid cycle (TCAC) metabolism, suggesting a distinct metabolic rewiring associated with its tumor-suppressive function. LN229 and T98G GBM cell lines were used as experimental models. Metabolomic profiling by liquid chromatography-mass spectrometry was performed to compare changes in central metabolic pathways following GLS2 or GLS overexpression. Glutaminase and PDH enzymatic activities were measured, and Western blotting was performed to assess GLS, GLS2, and PDHA1 protein levels and PDHA1 phosphorylation. A Seahorse analyzer was employed to quantify real-time ATP production derived from glycolysis and oxidative phosphorylation. Overexpression of GLS2, but not GLS, in LN229 cells caused the accumulation of TCAC-related metabolites, except for citrate, whose depletion is attributed to GLS2's effect on PDH phosphorylation, causing reduced PDH activity. This was accompanied by decreased levels of several acyl-carnitines. Furthermore, GLS2 induced the accumulation of glucose/fructose, while reducing levels of glucose-6-phosphate and pentose-phosphates, consistent with altered glycolysis. GLS2 also diminished the ATP/AMP ratio, confirmed by a reduced ATP synthesis rate, particularly glycolytic ATP, whereas mitochondrial ATP production remained unaltered. GLS2 exerts an isoenzyme-specific effect on Gln and glucose metabolism in GBM, likely modulating the glycolysis/pentose-phosphate pathway (PPP)-TCAC-axis.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about sodium ferrous citrate